Adalimumab (Humira) is a medication used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis, and ankylosing spondylitis. It is a type of biologic therapy, which means it is a drug that is made from living cells. Adalimumab works by blocking the action of certain proteins in the body that cause inflammation and joint damage. It is usually taken as an injection under the skin every other week.
Adalimumab, also known by the brand name Humira, is a prescription medication classified as a tumor necrosis factor (TNF) alpha inhibitor. It is a biologic drug, meaning it is produced from living cells and targets specific biological molecules involved in disease processes. Adalimumab is used to treat various chronic inflammatory conditions by reducing inflammation and suppressing the immune system.
Here's a breakdown of its key aspects:
Function:
Adalimumab works by binding to and blocking the activity of TNF-alpha, a pro-inflammatory cytokine (signaling molecule) involved in the immune system's inflammatory response. By blocking TNF-alpha, Adalimumab helps to:
- Reduce inflammation in affected tissues.
- Suppress the activity of immune cells that contribute to inflammation.
- Improve symptoms associated with various chronic inflammatory conditions.
Clinical use:
Adalimumab is primarily used to treat:
- Rheumatoid arthritis (RA): An autoimmune disease causing inflammation, pain, and swelling in the joints.
- Ankylosing spondylitis (AS): An inflammatory disease affecting the spine and joints.
- Psoriatic arthritis (PsA): A type of arthritis that affects people with psoriasis, a skin condition.
- Ulcerative colitis (UC): A chronic inflammatory bowel disease (IBD) causing inflammation and ulcers in the lining of the colon.
- Psoriasis: In moderate to severe cases, Adalimumab can help manage the inflammatory processes contributing to plaque psoriasis.
Dosage and administration:
- Adalimumab is typically administered by subcutaneous injection (under the skin) by a healthcare professional or trained individual.
- The specific dosage and frequency of injection will depend on the specific condition being treated, its severity, and individual factors, as determined by a healthcare professional.
Important to remember:
- Potential side effects: Adalimumab can cause side effects, including:
- Injection site reactions: Pain, redness, swelling, or itching at the injection site.
- Upper respiratory infections: Increased risk of infections like colds and flu.
- Headache
- Fatigue
- Nausea
- Stomach pain
- Increased risk of serious infections: In rare cases, Adalimumab can increase the risk of developing serious infections, including tuberculosis.
- Not for everyone: Adalimumab is not suitable for everyone and may interact with other medications or have increased risks in individuals with certain pre-existing health conditions. It's crucial to disclose your complete medical history and any medications you are taking to your doctor before starting treatment.
- Consult a healthcare professional: Consulting with a qualified healthcare professional is essential for diagnosis, treatment recommendations, and monitoring for potential side effects. They can determine if Adalimumab is the right medication for you and guide you on its appropriate use.
Disclaimer: This information is for general knowledge purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis, treatment, and personalized recommendations for any medical condition.